Home

Diana Brainard, CEO: Kalaris Therapeutics KLRS Sell · Filed 24/02/22

Trade details

Type
Insider sale
Amount
$3,660.05
Shares · price
5,155 sh · $0.71 a share
Held after
814,069 sh
Trade date
24/02/21
Filed
24/02/22
Days to filing
1 days

Sold 0.6% of holdings

Share of holding sold
0.6%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/22~24/03/22

Diana Brainard's recent trades

  • Diana Brainard

    SellKalaris Therapeutics

    $4,788

    Filed 24/11/20

  • Diana Brainard

    SellKalaris Therapeutics

    $9,124

    Filed 24/11/06

  • Diana Brainard

    SellKalaris Therapeutics

    $7,607

    Filed 24/10/23

  • Diana Brainard

    SellKalaris Therapeutics

    $1,209

    Filed 24/10/04

  • Diana Brainard

    SellKalaris Therapeutics

    $3,989

    Filed 24/08/22

Diana Brainard, CEO — sold $3,660 of Kalaris Therapeutics KLRS · 0.6% of holdings | Whalegun